Clinical trial · Interventional
Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours
NCT06339372CI-TRIAL-00075612completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study was to investigate the effect of adding omega 3 and dipeptiven to standard feeding in head and neck patients who will undergo oral cavity tumour resection or mandibular tumour resection (immunonutrrition mixture) on wound infection, fistula formation and length of hospital stay ,total dose of intraoperative and postoperative opioids (opioid consumption and pain incidence ,mortality and other postoperative complications as urinary tract infection (UTI) and pneumonia.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Immunonutrition | — | UNRESOLVED | — |
| Mandibular Tumor | — | UNRESOLVED | — |
| Oral Cavity | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Surgical Outcome | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Omega 3 and dipeptiven | Dietary Supplement | — | UNRESOLVED |
| Standard feeding | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Group A (standard feeding)
- description
- Patients received only standard feeding with caloric distribution (45%-50% carbohydrates,20-35% from fats and 10-35% from protein)
- interventionNames
- Dietary Supplement: Standard feeding
- type
- EXPERIMENTAL
- label
- Group B (immunonutrition mixture)
- description
- Patients received perioperative supplementation with omega 3 and dipeptiven (immunonutrition mixture) plus standard feeding.
- interventionNames
- Dietary Supplement: Omega 3 and dipeptiven
Primary outcomes (1)
- measure
- The incidence of wound infection
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 18 and 60 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I or II . * Patient undergoing mandibular or oral cavity tumour resection. * Body mass index (BMI) between 18.5-24.9. * Patient with serum albumen above 3 gm. * Patient with written valid consent Exclusion Criteria: * Patient refusal and uncooperative patients. * Patient ASA III or IV. * Age more than 60 or less than 18. * Serum albumen less than 3. * Pre-existing severe malnourishment. * Allergy to test drugs. * Patients on tranquilizers, hypnotics, sedatives and other psychotropic patient on steroids and NSAID.
References
Publications (0)
Data not yet available
No reference posted for this study.